Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 1 Similar Profiles
Experimental Arthritis Medicine & Life Sciences
Arthritis Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Immunoglobulin G Medicine & Life Sciences
Collagen Medicine & Life Sciences
Leukocytes Medicine & Life Sciences
Enzymes Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1967 2017

Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management

Oronsky, B., Caroen, S., Oronsky, A., Dobalian, V. E., Oronsky, N., Lybeck, M., Reid, T. R. & Carter, C. A. Jul 20 2017 (Accepted/In press) In : Cancer Chemotherapy and Pharmacology. p. 1-13 13 p.

Research output: Research - peer-reviewArticle

Platinum
Electrolytes
Drug Therapy
Therapeutics
Chemotherapy

No patient left behind: The promise of immune priming with epigenetic agents

Carter, C. A., Oronsky, B. T., Roswarski, J., Oronsky, A. L., Oronsky, N., Scicinski, J., Lybeck, H., Kim, M. M., Lybeck, M. & Reid, T. R. Sep 15 2017 (Accepted/In press) In : OncoImmunology.

Research output: Research - peer-reviewArticle

Epigenomics
Neoplasms
Immunotherapy
Therapeutics
Immunosuppression

RRx-001: a systemically non-toxic M2-to-M1 macrophage stimulating and prosensitizing agent in Phase II clinical trials

Oronsky, B. , Paulmurugan, R. , Foygel, K. , Scicinski, J. , Knox, S. J. , Peehl, D. , Zhao, H. , Ning, S. , Cabrales, P. , Summers, T. A. , Reid, T. R. , Fitch, W. L. , Kim, M. M. , Trepel, J. B. , Lee, M. J. , Kesari, S. , Abrouk, N. D. , Day, R. M. , Oronsky, A. , Ray, C. M. & 1 others Carterg, C. A. Jan 2 2017 In : Expert Opinion on Investigational Drugs. 26, 1, p. 109-119 11 p.

Research output: Research - peer-reviewArticle

Phase II Clinical Trials
Macrophages
Neoplasms
RRx-001
Growth

RRx-001 protects against cisplatin-induced toxicities

Oronsky, B., Reid, T. R., Larson, C., Carter, C. A., Brzezniak, C. E., Oronsky, A. & Cabrales, P. Apr 17 2017 (Accepted/In press) In : Journal of Cancer Research and Clinical Oncology. p. 1-7 7 p.

Research output: Research - peer-reviewArticle

Cisplatin
RRx-001
Creatinine
Metaphase
Kidney

The macrophage stimulating anti-cancer agent, RRx-001, protects against ischemia-reperfusion injury

Cabrales, P., Caroen, S., Oronsky, A., Carter, C., Trepel, J., Summers, T., Reid, T., Oronsky, N., Lybeck, M. & Oronsky, B. Jun 3 2017 In : Expert Review of Hematology. 10, 6, p. 575-582 8 p.

Research output: Research - peer-reviewArticle

Reperfusion Injury
Nitric Oxide
Ischemia
Macrophages
Neoplasms